§ 13-P — Comprehensive prescription drug formulary

§ 13-p. Comprehensive prescription drug formulary. The chair shall\nestablish a comprehensive prescription drug formulary on or before\nDecember thirty-first, two thousand seventeen. The prescription drug\nformulary shall include a tiered list of high-quality, cost-effective\nmedications that are pre-approved to be prescribed and dispensed, as\nwell as additional non-preferred drugs that can be prescribed with prior\napproval. Such prescription drug formulary, shall include but not be\nlimited to implementation of a pharmacy reimbursement strategy,\nadministration of a prescription drug rebate program for formulary\ndrugs, a pre-approval program, drug utilization review, and limitations\non the prescribing of compounded medications and compounded topical\npreparations. The board shall promulgate regulations to permit an\ninterested party to submit a request to the medical director of the\nboard to alter or amend the formulary to consider changing the status of\na drug from non-preferred to preferred. Regulations may include a\nprovision for reasonable costs and fees associated with the review.\n